HP
HealthInvest Partners Portfolio holdings
AUM
$234M
1-Year Return
10.88%
This Quarter Return
+7.77%
1 Year Return
+10.88%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$227M
AUM Growth
+$15.7M
(+7.4%)
Cap. Flow
+$2.8M
Cap. Flow
% of AUM
1.24%
Top 10 Holdings %
Top 10 Hldgs %
59.15%
Holding
41
New
5
Increased
10
Reduced
19
Closed
4
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$8.63M |
| 2 |
Intuitive Surgical
ISRG
|
+$7.6M |
| 3 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
+$3.88M |
| 4 |
Krystal Biotech
KRYS
|
+$2.58M |
| 5 |
VRNA
Verona Pharma
VRNA
|
+$2.2M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.94M |
| 2 |
UnitedHealth
UNH
|
+$4.93M |
| 3 |
Amicus Therapeutics
FOLD
|
+$3.08M |
| 4 |
Boston Scientific
BSX
|
+$2.21M |
| 5 |
Eli Lilly
LLY
|
+$2.04M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
NewAmsterdam Pharma
NAMS
$2.72B
| $2.21M | 0.97% |
107,783
-31,200
| -22% | -$639K |
|
|
VRNA
27
Verona Pharma
VRNA
$9.21B
| $2.2M | 0.97% |
+34,690
| New | +$2.2M |
|
28
iRhythm Technologies
IRTC
$5.78B
| $2.15M | 0.95% |
+20,547
| New | +$2.15M |
|
29
Summit Therapeutics
SMMT
$14.1B
| $2.03M | 0.89% |
105,077
+3,900
| +4% | +$75.2K |
|
30
Revolution Medicines
RVMD
$8.7B
| $1.94M | 0.86% |
54,961
-7,200
| -12% | -$255K |
|
|
BCAX
31
Bicara Therapeutics Inc. Common Stock
BCAX
$634M
| $1.56M | 0.69% |
+119,833
| New | +$1.56M |
|
32
Merus
MRUS
$5.26B
| $1.49M | 0.66% |
35,292
-27,229
| -44% | -$1.15M |
|
33
Janux Therapeutics
JANX
$1.45B
| $1.26M | 0.56% |
46,808
+7,235
| +18% | +$195K |
|
|
MREO
34
Mereo BioPharma
MREO
$294M
| $878K | 0.39% |
390,000
| – | – |
|
|
AUTL
35
Autolus Therapeutics
AUTL
$367M
| $743K | 0.33% |
479,644
| – | – |
|
36
Corbus Pharmaceuticals
CRBP
$116M
| $522K | 0.23% |
98,304
| – | – |
|
37
Cabaletta Bio
CABA
$168M
| $253K | 0.11% |
182,354
-65,100
| -26% | -$90.2K |
|
|
38
Amicus Therapeutics
FOLD
$2.46B
| – | – |
-326,840
| Closed | -$3.08M |
|
39
Mersana Therapeutics
MRSN
$35.6M
| – | – |
-21,545
| Closed | -$765K |
|
40
Pharvaris
PHVS
$1.49B
| – | – |
-34,328
| Closed | -$653K |
|
|
ITCI
41
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-71,138
| Closed | -$5.94M |
|